SNS Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Buy
6,517
+31
+0.5% +$7.22K 0.14% 63
2025
Q4
$1.34M Buy
6,486
+214
+3% +$42.3K 0.12% 71
2025
Q3
$1.16M Sell
6,272
-465
-7% -$79.7K 0.1% 81
2025
Q2
$1.03M Sell
6,737
-61
-0.9% -$9.38K 0.1% 84
2025
Q1
$1.13M Buy
6,798
+271
+4% +$42.4K 0.11% 77
2024
Q4
$944K Sell
6,527
-441
-6% -$68.3K 0.1% 86
2024
Q3
$1.13M Sell
6,968
-294
-4% -$46.8K 0.11% 84
2024
Q2
$1.06M Buy
7,262
+136
+2% +$20.2K 0.11% 83
2024
Q1
$1.13M Buy
7,126
+199
+3% +$31.7K 0.12% 79
2023
Q4
$1.09M Buy
6,927
+117
+2% +$17.9K 0.13% 77
2023
Q3
$1.06M Buy
6,810
+161
+2% +$26.6K 0.14% 74
2023
Q2
$1.1M Sell
6,649
-228
-3% -$36.8K 0.14% 77
2023
Q1
$1.07M Sell
6,877
-2,232
-25% -$360K 0.14% 80
2022
Q4
$1.61M Buy
9,109
+412
+5% +$71.1K 0.22% 60
2022
Q3
$1.42M Buy
8,697
+60
+0.7% +$10.2K 0.2% 66
2022
Q2
$1.53M Buy
8,637
+97
+1% +$17.3K 0.2% 65
2022
Q1
$1.51M Sell
8,540
-7
-0.1% -$1.19K 0.17% 79
2021
Q4
$1.46M Sell
8,547
-3
-0% -$491 0.16% 85
2021
Q3
$1.38M Sell
8,550
-359
-4% -$61.2K 0.17% 83
2021
Q2
$1.47M Buy
8,909
+301
+3% +$49.8K 0.19% 76
2021
Q1
$1.42M Sell
8,608
-39
-0.5% -$6.31K 0.19% 76
2020
Q4
$1.36M Buy
8,647
+74
+0.9% +$10.9K 0.19% 72
2020
Q3
$1.28M Buy
8,573
+138
+2% +$20.4K 0.2% 71
2020
Q2
$1.19M Buy
8,435
+101
+1% +$14.7K 0.22% 68
2020
Q1
$1.09M Sell
8,334
-258
-3% -$36.6K 0.21% 83
2019
Q4
$1.25M Buy
8,592
+118
+1% +$16K 0.22% 76
2019
Q3
$1.1M Sell
8,474
-827
-9% -$109K 0.21% 72
2019
Q2
$1.29M Buy
9,301
+271
+3% +$37.5K 0.24% 68
2019
Q1
$1.26M Sell
9,030
-118
-1% -$15.8K 0.28% 63
2018
Q4
$1.18M Buy
9,148
+402
+5% +$56.1K 0.29% 66
2018
Q3
$1.21M Sell
8,746
-46
-0.5% -$6.11K 0.29% 62
2018
Q2
$1.07M Sell
8,792
-1,450
-14% -$181K 0.28% 57
2018
Q1
$1.31M Sell
10,242
-6,594
-39% -$891K 0.36% 53
2017
Q4
$2.35M Buy
16,836
+614
+4% +$85.5K 0.57% 39
2017
Q3
$2.11M Buy
16,222
+208
+1% +$27.6K 0.54% 41
2017
Q2
$2.12M Sell
16,014
-79
-0.5% -$10.1K 0.56% 43
2017
Q1
$2M Buy
16,093
+4,556
+39% +$544K 0.52% 50
2016
Q4
$1.33M Buy
11,537
+6,373
+123% +$736K 0.39% 60
2016
Q3
$610K Buy
5,164
+200
+4% +$24.3K 0.18% 76
2016
Q2
$602K Buy
4,964
+2,584
+109% +$294K 0.15% 78
2016
Q1
$258K Sell
2,380
-415
-15% -$43K 0.07% 95
2015
Q4
$287K Sell
2,795
-3,608
-56% -$363K 0.07% 93
2015
Q3
$598K Buy
6,403
+336
+6% +$32.5K 0.16% 73
2015
Q2
$591K Buy
6,067
+3,200
+112% +$320K 0.18% 71
2015
Q1
$288K Buy
2,867
+600
+26% +$61K 0.1% 94
2014
Q4
$237K Sell
2,267
-149
-6% -$15.7K 0.09% 97
2014
Q3
$258K Sell
2,416
-103
-4% -$10.7K 0.08% 99
2014
Q2
$264K Sell
2,519
-15,991
-86% -$1.62M 0.11% 95
2014
Q1
$1.82M Sell
18,510
-8,969
-33% -$832K 0.81% 19
2013
Q4
$2.52M Buy
27,479
+4,152
+18% +$383K 1.16% 18
2013
Q3
$2.02M Buy
23,327
+5,093
+28% +$457K 1.28% 17
2013
Q2
$1.57M Buy
+18,234
New +$1.55M 0.59% 23

Other funds holding JNJ

SNS Financial Group's JNJ Position: Q1 2026 in Review

SNS Financial Group increased its Johnson & Johnson (JNJ) stake by 0.48% in Q1 2026, buying an estimated $7.22K and bringing the position to 6,517 shares worth $1.59M. The position accounts for 0.14% of the portfolio, ranked #63.

SNS Financial Group first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.52M in Q4 2013. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • SNS Financial Group held 6,517 shares of Johnson & Johnson worth $1.59M as of Q1 2026.
  • SNS Financial Group bought 31 Johnson & Johnson shares in Q1 2026, an estimated $7.22K.
  • Johnson & Johnson made up 0.14% of SNS Financial Group's portfolio in Q1 2026, its #63 holding.
  • SNS Financial Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • SNS Financial Group's Johnson & Johnson position peaked at $2.52M in Q4 2013.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.